DanCann Pharma A/S Sustainability Reports

DanCann Pharma A/S is a Danish biopharmaceutical company focused on the development, production, and distribution of standardized cannabinoid therapeutics and medicinal cannabis products. It establishes prescription and over-the-counter medicine alternatives targeted primarily at patients with chronic diseases and alternative therapeutic needs.

Sector: Manufacturing

Country: Denmark

Exchange: Nordic Growth Market

LEI: 549300KLXQ6IC2YUUB58

FIGI: BBG00XRCXP54

4 reports from 2020 to 2024

• DanCann Pharma A/S 2024 Annual Report
• DanCann Pharma A/S 2023 Annual Report
• DanCann Pharma A/S 2021 Annual Report
• DanCann Pharma A/S 2020 Annual Report